Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arrowhead Pharmaceuticals Inc. buy Chardan Capital

Start price
€20.70
10.05.24 / 50%
Target price
€55.70
10.05.25
Performance (%)
10.82%
Price
€22.94
24.05.24
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 10.82%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w
Arrowhead Pharmaceuticals Inc. -0.348%
iShares Core DAX® -0.205%
iShares Nasdaq 100 1.613%
iShares Nikkei 225® -0.740%
iShares S&P 500 0.267%

Comments by Chardan_Capital for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 10.82%
Target price 55.698
Change
Ends at 10.05.25

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat

Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.07
08.08.23
€54.73
08.08.24
-8.50%
24.05.24